August Sigle
About
August Sigle is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Urology.
According to data from OpenAlex, August Sigle has authored 52 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 18 papers in Rheumatology and 14 papers in Urology. Recurrent topics in August Sigle's work include Prostate Cancer Diagnosis and Treatment (39 papers), Prostate Cancer Treatment and Research (23 papers) and Urologic and reproductive health conditions (14 papers). August Sigle is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (39 papers), Prostate Cancer Treatment and Research (23 papers) and Urologic and reproductive health conditions (14 papers). August Sigle collaborates with scholars based in Germany, Switzerland and Austria. August Sigle's co-authors include Christian Gratzke, Matthias Benndorf, Fabian Bamberg, Hannes Engel, Arkadiusz Miernik, Rodrigo Suarez-Ibarrola, Wolfgang Schultze‐Seemann, Cordula A. Jilg, Markus Grabbert and Anca-Ligia Grosu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.
In The Last Decade
August Sigle
41 papers receiving 473 citations
Peers
August Sigle
Sébastien Bouye France
Andreas Maxeiner Germany
D. Bruce Sodee United States
Hong Hong Huang Singapore
Sonia Gaur United States
Annerleim Walton‐Diaz United States
Niklas Westhoff Germany
Amirhossein Mohammadian Bajgiran United States
Sandeep Gurram United States
Nicola L. Robertson United States
Citations per year, relative to August Sigle August Sigle (= 1×)
peers
Sébastien Bouye
Countries citing papers authored by August Sigle
Since
Specialization
Citations
This map shows the geographic impact of August Sigle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by August Sigle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites August Sigle more than expected).
Fields of papers citing papers by August Sigle
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by August Sigle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by August Sigle. The network helps show where August Sigle may publish in the future.
Co-authorship network of co-authors of August Sigle
This figure shows the co-authorship network connecting the top 25 collaborators of August Sigle. A scholar is included among the top collaborators of August Sigle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with August Sigle. August Sigle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Waibel, P, Tobias Fechter, Michael Mix, et al.. (2025). Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007. European Journal of Nuclear Medicine and Molecular Imaging. 52(6). 2023–2033.
2.
Engel, Hannes, Caroline Wilpert, August Sigle, et al.. (2025). Multi-Center Benchmarking of a Commercially Available Artificial Intelligence Algorithm for Prostate Imaging Reporting and Data System (PI-RADS) Score Assignment and Lesion Detection in Prostate MRI. Cancers. 17(5). 815–815.
3.
Engel, Hannes, Robert Grimm, Heinrich von Busch, et al.. (2025). Diagnostic performance of a fully automated AI algorithm for lesion detection and PI-RADS classification in patients with suspected prostate cancer. La radiologia medica. 130(7). 1039–1049.
4.
Sigle, August, et al.. (2025). Mastering HoLEP: Learning Curves and Perioperative Complications in Holmium Laser Enucleation of the Prostate. Journal of Endourology. 39(8). 849–855.
5.
Urban, Sylvia, Judith M. Müller, Qing Wang, et al.. (2025). Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth. Nature Communications. 16(1). 1191–1191.
6.
Grabbert, Markus, Constantinos Zamboglou, Simon K. B. Spohn, et al.. (2024). SALVAGE RADIOTHERAPY IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PSA PERSISTENCE OR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY DUE TO PROSTATE CANCER. Urologic Oncology Seminars and Original Investigations. 42. S17–S17.
7.
Engel, Hannes, Christine Schmucker, Guido Schwarzer, et al.. (2024). Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis. Radiology. 312(2). e233337–e233337.
8.
Tonyalı, Şenol, August Sigle, Konrad Wilhelm, et al.. (2024). Real-world experience with the new pulsed solid-state Thulium: YAG laser (Thulio) for endoscopic enucleation of the prostate. World Journal of Urology. 42(1). 467–467.
9.
Metzger, Patrick, Martin Werner, Cornelius Miething, et al.. (2024). Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor Board. Urologia Internationalis. 108(5). 383–391.
10.
Grabbert, Markus, Daniel Schlager, August Sigle, et al.. (2024). Aquablation versus HoLEP in patients with benign prostatic hyperplasia: a comparative prospective non-randomized study. World Journal of Urology. 42(1). 306–306.
11.
Saba, Karim, August Sigle, Christian Wetterauer, et al.. (2023). Prospective Multicenter Validation of the Stockholm3 Test in a Central European Cohort. European Urology Focus. 10(4). 620–626.
12.
Sigle, August, Michael Mix, Juri Ruf, et al.. (2023). Toxicity and Patient Reported Quality of Life after PSMA-PET and mpMRT-Based Focal Dose Escalated Definitive Radiotherapy in Prostate Cancer Patients: 2-Year Follow-Up of the HypoFocal Phase II Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). S95–S95.
13.
Engel, Hannes, Christopher L. Schlett, Robert Grimm, et al.. (2023). Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: Performance of a fully automated AI‐algorithm for lesion detection and classification. The Prostate. 83(9). 871–878.
14.
Sigle, August, Cordula A. Jilg, Boris Schlenker, et al.. (2022). Development and Implementation of an Advanced Program for Robotic Treatment of Prostate Cancer—Is Surgical Quality Transferable?. Cancers. 14(21). 5261–5261.
15.
Binder, Nadine, Kathrin Möllenhoff, August Sigle, & Holger Dette. (2022). Similarity of competing risks models with constant intensities in an application to clinical healthcare pathways involving prostate cancer surgery. Statistics in Medicine. 41(19). 3804–3819.
16.
Sigle, August, Matthias Benndorf, Lars Schimmöller, et al.. (2022). Bildgesteuerte Biopsie der Prostata. PubMed. 61(10). 1137–1148.
17.
Spohn, Simon K. B., Juri Ruf, Michael Mix, et al.. (2022). Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate Cancer. Frontiers in Oncology. 12. 898774–898774.
18.
Engel, Hannes, et al.. (2021). Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level. Prostate Cancer and Prostatic Diseases. 25(2). 256–263.
19.
Sigle, August, Rodrigo Suarez-Ibarrola, Cordula A. Jilg, et al.. (2021). Safety and side effects of transperineal prostate biopsy without antibiotic prophylaxis. Urologic Oncology Seminars and Original Investigations. 39(11). 782.e1–782.e5.
20.
Grabbert, Markus, August Sigle, Michael Mix, et al.. (2021). Long-term Clinical Outcomes of Repeat Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: A Case Series. European Urology Focus. 8(2). 425–430.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sébastien Bouye Breakdown of academic impact, for papers by Andreas Maxeiner Breakdown of academic impact, for papers by D. Bruce Sodee Breakdown of academic impact, for papers by Hong Hong Huang Breakdown of academic impact, for papers by Sonia Gaur Breakdown of academic impact, for papers by Annerleim Walton‐Diaz Breakdown of academic impact, for papers by Niklas Westhoff Breakdown of academic impact, for papers by Amirhossein Mohammadian Bajgiran Breakdown of academic impact, for papers by Sandeep Gurram Breakdown of academic impact, for papers by Nicola L. Robertson